Home
About
Services
Partners
Client Portfolio
News
Contact
Japan says Mazda, Suzuki, Yamaha Motor carried out improper testing
August 9, 2018
Musk’s Tesla buyout plan could test Wall Street’s nerves
August 9, 2018
0
Perrigo board okays separation of prescription pharma business
Published by
Muller&Green
at
August 9, 2018
Categories
RSS
Tags
Perrigo Company Plc said on Thursday its board approved a plan to separate its Prescription Pharmaceuticals (Rx) business after the generic drugmaker completed a review of its strategic portfolio.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more